Field Medical Director, Cell Therapy at Bristol-Myers Squibb

United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, PharmaceuticalsIndustries

Requirements

Therapeutic area expertise in PAN-CAR T products
Ability to serve as clinical/scientific leader for approved CAR T products and compounds in clinical development
Experience in strategic and tactical planning for medical affairs programs
Capability to represent US Medical Affairs as a point of contact for field medical teams, sites, and stakeholders

Responsibilities

Serve as primary medical director point of contact for field medical team (MSL) and CAR T sites within designated region
Act as primary medical point of contact for sites of care related to non-conforming product, special treatment scenarios, and OOS
Ensure positive first CAR T clinical experience for each product at individual sites
Educate sites of care on non-conforming communication processes and ensure optimal communication and partnership with sites
Collaborate on various Medical Affairs cross-functional working groups, prioritizing activities related to manufacturing success and TAT improvements
Evaluate, assess, design, enhance, and develop long- and short-term strategies (1-5 years) to enhance the impact of Cell Therapy Medical Affairs with customers related to non-conforming product
Monitor insights to inform and educate stakeholders, developing action plans as needed
Provide high-quality clinical input and review of CAR T strategy plans, abstracts, posters, slides, manuscripts, educational materials, steering committee and advisory board meeting objectives, Medical information letters, and Commercial Brand plans
Establish and maintain strong relationships with external partners, including high-profile academic institutions, industry leaders, hospital networks, and community organizations
Collaborate with internal and external stakeholders to influence process change
Collaborate with internal disease leads to ensure alignment on strategic medical initiatives related to manufacturing improvements
Serve as a liaison between the company and external stakeholders to facilitate collaboration and information sharing
Act as point of escalation for nonconforming CAR T products and special treatment scenarios, including off-label requests, re-treatment, and infectious disease-related clinical scenarios
Understand and develop site points of pain problem lists with clinical relevance
Collaborate with Medical Affairs launch leads to define, guide, and execute CAR T strategies and tactics with appropriate use of resources
Support CAR T medical affairs studies (e.g., registries, protocols)
Provide therapy area medical and scientific expertise to clinical study teams and key stakeholders
Represent US Medical Affairs as needed, serving as a therapeutic area expert in PAN-CAR T products

Skills

CAR-T

Cell Therapy

Medical Affairs

MSL

Clinical Leadership

Field Medical

Site Management

Therapeutic Expertise

Nonconforming Products

Clinical Development

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free